Lexon former director Sonpal disqualified by UK CMA over anticompetitive drug practices
MLex Summary: The UK's Competition and Markets Authority has said it has secured the disqualification of former Lexon director Pritesh Sonpal for his role in anticompetitive practices. In March 2020, the...To view the full article, register now.
Already a subscriber? Click here to view full article